» Articles » PMID: 10999845

Heterogeneity of Nuclear Lamin A Mutations in Dunnigan-type Familial Partial Lipodystrophy

Overview
Specialty Endocrinology
Date 2000 Sep 22
PMID 10999845
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

We previously identified a novel mutation, namely LMNA R482Q, that was found to underlie Dunnigan-type partial lipodystrophy (FPLD) and diabetes in an extended Canadian kindred. We have since sequenced LMNA in five additional Canadian FPLD probands and herein report three new rare missense mutations in LMNA: V440M, R482W, and R584H. One severely affected subject was a compound heterozygote for both V440M and R482Q. The findings indicated that 1) a spectrum of LMNA mutations underlies FPLD; 2) aberrant lamin A, and not lamin C, is likely to underlie FPLD, as R584H occurs within LMNA sequence that is specific for lamin A; 3) the V440M mutation may not cause lipodystrophy on its own; 4) compound heterozygosity for V440M and R482Q is associated with a relatively more severe FPLD phenotype, but not with complete lipodystrophy; and 5) variation in the severity of the phenotype might be related to environmental factors.

Citing Articles

Anthropometric measurements as a key diagnostic tool for familial partial lipodystrophy in women.

Veras V, da Cruz Paiva Lima G, da Ponte Melo I, Fernandes V, de Moura Lopes F, do Amaral C Diabetol Metab Syndr. 2024; 16(1):216.

PMID: 39227868 PMC: 11373399. DOI: 10.1186/s13098-024-01413-w.


Case report: two novel PPARG pathogenic variants associated with type 3 familial partial lipodystrophy in Brazil.

da Silva M, Soares R, de Oliveira Filho A, Campos L, de Lima J, de Melo Campos J Diabetol Metab Syndr. 2024; 16(1):145.

PMID: 38951919 PMC: 11218129. DOI: 10.1186/s13098-024-01387-9.


Deciphering the Clinical Presentations in LMNA-related Lipodystrophy: Report of 115 Cases and a Systematic Review.

Besci O, Foss de Freitas M, Guidorizzi N, Celik Guler M, Gilio D, Maung J J Clin Endocrinol Metab. 2023; 109(3):e1204-e1224.

PMID: 37843397 PMC: 10876415. DOI: 10.1210/clinem/dgad606.


A promising treatment for spontaneous ovarian hyperstimulation syndrome due to familial partial lipodystrophy: GnRH analogs combined with cyst aspiration.

Gokcay Canpolat A, Aslan B, Sukur Y Hormones (Athens). 2023; 22(4):741-745.

PMID: 37491654 DOI: 10.1007/s42000-023-00469-z.


Clinical Spectrum of -Associated Type 2 Familial Partial Lipodystrophy: A Systematic Review.

Fernandez-Pombo A, Diaz-Lopez E, Castro A, Sanchez-Iglesias S, Cobelo-Gomez S, Prado-Morana T Cells. 2023; 12(5).

PMID: 36899861 PMC: 10000975. DOI: 10.3390/cells12050725.